Legal & Disputes
Globe Life Discloses $7 Million in Excess Medicare Supplement Claims as Shares Fall 8%
By News Desk ·
Key takeaways
- Globe Life disclosed approximately $7 million in excess prior-period Medicare Supplement claims tied to a CMS processing delay.
- United American, Globe Life's Medicare Supplement division, reported a negative $6 million health underwriting margin on $219 million in health premiums for the quarter ended September 30, 2026.
- SueWallSt, powered by Levi & Korsinsky LLP, notified investors of a pending investigation into potential securities law violations concerning Globe Life's disclosure of its CMS claims exposure.
Globe Life Inc. disclosed approximately $7 million in excess prior-period Medicare Supplement claims tied to a processing delay at the Centers for Medicare & Medicaid Services, and its shares fell over 8% on October 23, 2026. SueWallSt notified investors of a pending investigation into potential securities law violations, according to PR Newswire.
Globe Life's Third-Quarter Claims Disclosure
The excess claims landed in United American, the Globe Life division that writes Medicare Supplement coverage. For the quarter ended September 30, 2026, United American reported a health underwriting margin of negative $6 million on $219 million in health premiums. Globe Life said the excess claims related to prior periods and were paid because of the CMS processing delay. United American's health premiums rose 29% year over year, and health sales climbed 95% to $48 million. Globe Life reported the CMS-related claims with its third-quarter results on October 22, 2026.
The investigation concerns whether Globe Life may not have adequately disclosed its exposure to CMS claims-processing changes before that date. Joseph E. Levi, Esq. of Levi & Korsinsky said investors who bought Globe Life stock and are looking at losses can submit their loss details. "Eligibility is based on purchase date and documented losses -- not on whether you still hold the shares," the notice states.
Globe Life's Scale and Capital Moves
Globe Life is a publicly traded U.S. insurance holding company that underwrites life insurance, supplemental health, Medicare Supplement, and group benefits for middle-income American households through 17,000 captive agents and direct-to-consumer channels, according to akta.pro company records. The same records show full-year 2025 revenue of $6.02 billion and a market capitalization of $13.65 billion as of June 2026, when the stock reached an all-time high of $176.31. In April 2026, Globe Life completed a $1.2 billion Bermuda reinsurance transaction through its newly established Globe Life Re Ltd. subsidiary.
Earlier Globe Life Developments
On October 26, 2026, Levi & Korsinsky commenced an investigation into Globe Life for potential securities fraud, after shares fell 8.09% when management cut its full-year 2026 earnings outlook, citing health-insurance underwriting pressures and a third-quarter earnings miss, The future of trading reported. Globe Life set its third-quarter 2026 earnings release for October 21, 2026, with a conference call, Stock Titan reported on October 19, 2026. In September 2026, Globe Life reported second-quarter revenues of $1.59 billion, up 6.1% year on year, but missed book value and EPS estimates, sending its stock down 7% to $171.17, Yahoo reported.
What Comes Next for Globe Life
Globe Life released its third-quarter 2026 financial results after the market close on October 21, 2026, and held a conference call for the release. The SueWallSt investigation remains pending, and investors may submit brokerage records showing purchase dates, share quantities, and prices paid.